APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Cyclizine

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Cyclizine Market Analysis and Forecast 2026-2032

Report ID 173981880219 December 2025198 pages

Choose your research edition.

Industry ResearchCyclizine Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Cyclizine Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Cyclizine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cyclizine Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Cyclizine Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Cyclizine market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Cyclizine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Cyclizine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Cyclizine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Cyclizine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Cyclizine include Teva, Glaxosmithkline, Wockhardt UK, Wabosan Arzneimittel, Pharmascript Limited, P and D Pharmaceuticals, Be-Tabs Pharmaceuticals, Aspen Pharmacare and Amoun Pharmaceutical, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Cyclizine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Cyclizine, also provides the sales of main regions and countries. Of the upcoming market potential for Cyclizine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Cyclizine sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Cyclizine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Cyclizine sales, projected growth trends, production technology, application and end-user industry.

Cyclizine Segment by Company

Teva

Glaxosmithkline

Wockhardt UK

Wabosan Arzneimittel

Pharmascript Limited

P and D Pharmaceuticals

Be-Tabs Pharmaceuticals

Aspen Pharmacare

Amoun Pharmaceutical

Amco

Aft Pharmaceuticals

Advanz Pharma

Cyclizine Segment by Type

Oral

Injection

Cyclizine Segment by Application

Migraine

Motion Sickness

Cyclizine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cyclizine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cyclizine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cyclizine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Cyclizine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Cyclizine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cyclizine sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Cyclizine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Oral Major Manufacturers Table 3. Injection Major Manufacturers Table 4. Global Cyclizine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Migraine Major Manufacturers Table 6. Motion Sickness Major Manufacturers Table 7. Cyclizine Industry Trends Table 8. Cyclizine Industry Drivers Table 9. Cyclizine Industry Opportunities and Challenges Table 10. Cyclizine Industry Restraints Table 11. Global Cyclizine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global Cyclizine Revenue by Region (2021-2026) & (US$ Million) Table 13. Global Cyclizine Revenue by Region (2027-2032) & (US$ Million) Table 14. Global Cyclizine Revenue Market Share by Region (2021-2026) Table 15. Global Cyclizine Revenue Market Share by Region (2027-2032) Table 16. Global Cyclizine Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 17. Global Cyclizine Sales by Region (2021-2026) & (K Units) Table 18. Global Cyclizine Sales by Region (2027-2032) & (K Units) Table 19. Global Cyclizine Sales Market Share by Region (2021-2026) Table 20. Global Cyclizine Sales Market Share by Region (2027-2032) Table 21. Global Cyclizine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global Cyclizine Revenue Market Share by Manufacturers (2021-2026) Table 23. Global Cyclizine Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Cyclizine Sales Market Share by Manufacturers (2021-2026) Table 25. Global Cyclizine Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 26. Global Cyclizine Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global Cyclizine Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global Cyclizine Manufacturers, Product Type & Application Table 29. Global Cyclizine Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Cyclizine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Cyclizine Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Cyclizine Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Cyclizine Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Cyclizine Revenue Market Share by Type (2021-2026) Table 36. Global Cyclizine Revenue Market Share by Type (2027-2032) Table 37. Global Cyclizine Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 38. Global Cyclizine Sales by Type (2021-2026) & (K Units) Table 39. Global Cyclizine Sales by Type (2027-2032) & (K Units) Table 40. Global Cyclizine Sales Market Share by Type (2021-2026) Table 41. Global Cyclizine Sales Market Share by Type (2027-2032) Table 42. Global Cyclizine Price by Type (2021-2026) & (US$/Unit) Table 43. Global Cyclizine Price by Type (2027-2032) & (US$/Unit) Table 44. Global Cyclizine Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Cyclizine Revenue by Application (2021-2026) & (US$ Million) Table 46. Global Cyclizine Revenue by Application (2027-2032) & (US$ Million) Table 47. Global Cyclizine Revenue Market Share by Application (2021-2026) Table 48. Global Cyclizine Revenue Market Share by Application (2027-2032) Table 49. Global Cyclizine Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 50. Global Cyclizine Sales by Application (2021-2026) & (K Units) Table 51. Global Cyclizine Sales by Application (2027-2032) & (K Units) Table 52. Global Cyclizine Sales Market Share by Application (2021-2026) Table 53. Global Cyclizine Sales Market Share by Application (2027-2032) Table 54. Global Cyclizine Price by Application (2021-2026) & (US$/Unit) Table 55. Global Cyclizine Price by Application (2027-2032) & (US$/Unit) Table 56. Teva Company Information Table 57. Teva Business Overview Table 58. Teva Cyclizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 59. Teva Cyclizine Product Portfolio Table 60. Teva Recent Development Table 61. Glaxosmithkline Company Information Table 62. Glaxosmithkline Business Overview Table 63. Glaxosmithkline Cyclizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 64. Glaxosmithkline Cyclizine Product Portfolio Table 65. Glaxosmithkline Recent Development Table 66. Wockhardt UK Company Information Table 67. Wockhardt UK Business Overview Table 68. Wockhardt UK Cyclizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. Wockhardt UK Cyclizine Product Portfolio Table 70. Wockhardt UK Recent Development Table 71. Wabosan Arzneimittel Company Information Table 72. Wabosan Arzneimittel Business Overview Table 73. Wabosan Arzneimittel Cyclizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Wabosan Arzneimittel Cyclizine Product Portfolio Table 75. Wabosan Arzneimittel Recent Development Table 76. Pharmascript Limited Company Information Table 77. Pharmascript Limited Business Overview Table 78. Pharmascript Limited Cyclizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Pharmascript Limited Cyclizine Product Portfolio Table 80. Pharmascript Limited Recent Development Table 81. P and D Pharmaceuticals Company Information Table 82. P and D Pharmaceuticals Business Overview Table 83. P and D Pharmaceuticals Cyclizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. P and D Pharmaceuticals Cyclizine Product Portfolio Table 85. P and D Pharmaceuticals Recent Development Table 86. Be-Tabs Pharmaceuticals Company Information Table 87. Be-Tabs Pharmaceuticals Business Overview Table 88. Be-Tabs Pharmaceuticals Cyclizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Be-Tabs Pharmaceuticals Cyclizine Product Portfolio Table 90. Be-Tabs Pharmaceuticals Recent Development Table 91. Aspen Pharmacare Company Information Table 92. Aspen Pharmacare Business Overview Table 93. Aspen Pharmacare Cyclizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Aspen Pharmacare Cyclizine Product Portfolio Table 95. Aspen Pharmacare Recent Development Table 96. Amoun Pharmaceutical Company Information Table 97. Amoun Pharmaceutical Business Overview Table 98. Amoun Pharmaceutical Cyclizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Amoun Pharmaceutical Cyclizine Product Portfolio Table 100. Amoun Pharmaceutical Recent Development Table 101. Amco Company Information Table 102. Amco Business Overview Table 103. Amco Cyclizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Amco Cyclizine Product Portfolio Table 105. Amco Recent Development Table 106. Aft Pharmaceuticals Company Information Table 107. Aft Pharmaceuticals Business Overview Table 108. Aft Pharmaceuticals Cyclizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Aft Pharmaceuticals Cyclizine Product Portfolio Table 110. Aft Pharmaceuticals Recent Development Table 111. Advanz Pharma Company Information Table 112. Advanz Pharma Business Overview Table 113. Advanz Pharma Cyclizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Advanz Pharma Cyclizine Product Portfolio Table 115. Advanz Pharma Recent Development Table 116. North America Cyclizine Revenue by Type (2021-2026) & (US$ Million) Table 117. North America Cyclizine Revenue by Type (2027-2032) & (US$ Million) Table 118. North America Cyclizine Sales by Type (2021-2026) & (K Units) Table 119. North America Cyclizine Sales by Type (2027-2032) & (K Units) Table 120. North America Cyclizine Sales Price by Type (2021-2026) & (US$/Unit) Table 121. North America Cyclizine Sales Price by Type (2027-2032) & (US$/Unit) Table 122. North America Cyclizine Revenue by Application (2021-2026) & (US$ Million) Table 123. North America Cyclizine Revenue by Application (2027-2032) & (US$ Million) Table 124. North America Cyclizine Sales by Application (2021-2026) & (K Units) Table 125. North America Cyclizine Sales by Application (2027-2032) & (K Units) Table 126. North America Cyclizine Sales Price by Application (2021-2026) & (US$/Unit) Table 127. North America Cyclizine Sales Price by Application (2027-2032) & (US$/Unit) Table 128. North America Cyclizine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 129. North America Cyclizine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 130. North America Cyclizine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 131. North America Cyclizine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 132. North America Cyclizine Sales by Country (2021-2026) & (K Units) Table 133. North America Cyclizine Sales by Country (2027-2032) & (K Units) Table 134. North America Cyclizine Sales Price by Country (2021-2026) & (US$/Unit) Table 135. North America Cyclizine Sales Price by Country (2027-2032) & (US$/Unit) Table 136. United States Cyclizine Revenue (2021-2032) & (US$ Million) Table 137. Canada Cyclizine Revenue (2021-2032) & (US$ Million) Table 138. Europe Cyclizine Revenue by Type (2021-2026) & (US$ Million) Table 139. Europe Cyclizine Revenue by Type (2027-2032) & (US$ Million) Table 140. Europe Cyclizine Sales by Type (2021-2026) & (K Units) Table 141. Europe Cyclizine Sales by Type (2027-2032) & (K Units) Table 142. Europe Cyclizine Sales Price by Type (2021-2026) & (US$/Unit) Table 143. Europe Cyclizine Sales Price by Type (2027-2032) & (US$/Unit) Table 144. Europe Cyclizine Revenue by Application (2021-2026) & (US$ Million) Table 145. Europe Cyclizine Revenue by Application (2027-2032) & (US$ Million) Table 146. Europe Cyclizine Sales by Application (2021-2026) & (K Units) Table 147. Europe Cyclizine Sales by Application (2027-2032) & (K Units) Table 148. Europe Cyclizine Sales Price by Application (2021-2026) & (US$/Unit) Table 149. Europe Cyclizine Sales Price by Application (2027-2032) & (US$/Unit) Table 150. Europe Cyclizine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 151. Europe Cyclizine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 152. Europe Cyclizine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 153. Europe Cyclizine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 154. Europe Cyclizine Sales by Country (2021-2026) & (K Units) Table 155. Europe Cyclizine Sales by Country (2027-2032) & (K Units) Table 156. Europe Cyclizine Sales Price by Country (2021-2026) & (US$/Unit) Table 157. Europe Cyclizine Sales Price by Country (2027-2032) & (US$/Unit) Table 158. Germany Cyclizine Revenue (2021-2032) & (US$ Million) Table 159. France Cyclizine Revenue (2021-2032) & (US$ Million) Table 160. U.K. Cyclizine Revenue (2021-2032) & (US$ Million) Table 161. Italy Cyclizine Revenue (2021-2032) & (US$ Million) Table 162. Netherlands Cyclizine Revenue (2021-2032) & (US$ Million) Table 163. China Cyclizine Revenue by Type (2021-2026) & (US$ Million) Table 164. China Cyclizine Revenue by Type (2027-2032) & (US$ Million) Table 165. China Cyclizine Sales by Type (2021-2026) & (K Units) Table 166. China Cyclizine Sales by Type (2027-2032) & (K Units) Table 167. China Cyclizine Sales Price by Type (2021-2026) & (US$/Unit) Table 168. China Cyclizine Sales Price by Type (2027-2032) & (US$/Unit) Table 169. China Cyclizine Revenue by Application (2021-2026) & (US$ Million) Table 170. China Cyclizine Revenue by Application (2027-2032) & (US$ Million) Table 171. China Cyclizine Sales by Application (2021-2026) & (K Units) Table 172. China Cyclizine Sales by Application (2027-2032) & (K Units) Table 173. China Cyclizine Sales Price by Application (2021-2026) & (US$/Unit) Table 174. China Cyclizine Sales Price by Application (2027-2032) & (US$/Unit) Table 175. Asia Cyclizine Revenue by Type (2021-2026) & (US$ Million) Table 176. Asia Cyclizine Revenue by Type (2027-2032) & (US$ Million) Table 177. Asia Cyclizine Sales by Type (2021-2026) & (K Units) Table 178. Asia Cyclizine Sales by Type (2027-2032) & (K Units) Table 179. Asia Cyclizine Sales Price by Type (2021-2026) & (US$/Unit) Table 180. Asia Cyclizine Sales Price by Type (2027-2032) & (US$/Unit) Table 181. Asia Cyclizine Revenue by Application (2021-2026) & (US$ Million) Table 182. Asia Cyclizine Revenue by Application (2027-2032) & (US$ Million) Table 183. Asia Cyclizine Sales by Application (2021-2026) & (K Units) Table 184. Asia Cyclizine Sales by Application (2027-2032) & (K Units) Table 185. Asia Cyclizine Sales Price by Application (2021-2026) & (US$/Unit) Table 186. Asia Cyclizine Sales Price by Application (2027-2032) & (US$/Unit) Table 187. Asia Cyclizine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 188. Asia Cyclizine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 189. Asia Cyclizine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 190. Asia Cyclizine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 191. Asia Cyclizine Sales by Country (2021-2026) & (K Units) Table 192. Asia Cyclizine Sales by Country (2027-2032) & (K Units) Table 193. Asia Cyclizine Sales Price by Country (2021-2026) & (US$/Unit) Table 194. Asia Cyclizine Sales Price by Country (2027-2032) & (US$/Unit) Table 195. Japan Cyclizine Revenue (2021-2032) & (US$ Million) Table 196. South Korea Cyclizine Revenue (2021-2032) & (US$ Million) Table 197. India Cyclizine Revenue (2021-2032) & (US$ Million) Table 198. Australia Cyclizine Revenue (2021-2032) & (US$ Million) Table 199. China Taiwan Cyclizine Revenue (2021-2032) & (US$ Million) Table 200. Southeast Asia Cyclizine Revenue (2021-2032) & (US$ Million) Table 201. SAMEA Cyclizine Revenue by Type (2021-2026) & (US$ Million) Table 202. SAMEA Cyclizine Revenue by Type (2027-2032) & (US$ Million) Table 203. SAMEA Cyclizine Sales by Type (2021-2026) & (K Units) Table 204. SAMEA Cyclizine Sales by Type (2027-2032) & (K Units) Table 205. SAMEA Cyclizine Sales Price by Type (2021-2026) & (US$/Unit) Table 206. SAMEA Cyclizine Sales Price by Type (2027-2032) & (US$/Unit) Table 207. SAMEA Cyclizine Revenue by Application (2021-2026) & (US$ Million) Table 208. SAMEA Cyclizine Revenue by Application (2027-2032) & (US$ Million) Table 209. SAMEA Cyclizine Sales by Application (2021-2026) & (K Units) Table 210. SAMEA Cyclizine Sales by Application (2027-2032) & (K Units) Table 211. SAMEA Cyclizine Sales Price by Application (2021-2026) & (US$/Unit) Table 212. SAMEA Cyclizine Sales Price by Application (2027-2032) & (US$/Unit) Table 213. SAMEA Cyclizine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 214. SAMEA Cyclizine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 215. SAMEA Cyclizine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 216. SAMEA Cyclizine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 217. SAMEA Cyclizine Sales by Country (2021-2026) & (K Units) Table 218. SAMEA Cyclizine Sales by Country (2027-2032) & (K Units) Table 219. SAMEA Cyclizine Sales Price by Country (2021-2026) & (US$/Unit) Table 220. SAMEA Cyclizine Sales Price by Country (2027-2032) & (US$/Unit) Table 221. Brazil Cyclizine Revenue (2021-2032) & (US$ Million) Table 222. Argentina Cyclizine Revenue (2021-2032) & (US$ Million) Table 223. Chile Cyclizine Revenue (2021-2032) & (US$ Million) Table 224. Colombia Cyclizine Revenue (2021-2032) & (US$ Million) Table 225. Peru Cyclizine Revenue (2021-2032) & (US$ Million) Table 226. Saudi Arabia Cyclizine Revenue (2021-2032) & (US$ Million) Table 227. Israel Cyclizine Revenue (2021-2032) & (US$ Million) Table 228. UAE Cyclizine Revenue (2021-2032) & (US$ Million) Table 229. Turkey Cyclizine Revenue (2021-2032) & (US$ Million) Table 230. Iran Cyclizine Revenue (2021-2032) & (US$ Million) Table 231. Egypt Cyclizine Revenue (2021-2032) & (US$ Million) Table 232. Key Raw Materials Table 233. Raw Materials Key Suppliers Table 234. Cyclizine Distributors List Table 235. Cyclizine Customers List Table 236. Research Programs/Design for This Report Table 237. Authors List of This Report Table 238. Secondary Sources Table 239. Primary Sources List of Figures Figure 1. Cyclizine Image Figure 2. Global Cyclizine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cyclizine Market Size Share 2021 VS 2025 VS 2032 Figure 4. Oral Image Figure 5. Injection Image Figure 6. Global Cyclizine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Cyclizine Market Size Share 2021 VS 2025 VS 2032 Figure 8. Migraine Image Figure 9. Motion Sickness Image Figure 10. Global Cyclizine Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Cyclizine Revenue (2021-2032) & (US$ Million) Figure 12. Global Cyclizine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global Cyclizine Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global Cyclizine Revenue Market Share by Region (2021-2032) Figure 15. Global Cyclizine Sales (2021-2032) & (K Units) Figure 16. Global Cyclizine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 17. Global Cyclizine Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico Cyclizine Sales YoY (2021-2032) & (K Units) Figure 19. Europe Cyclizine Sales YoY (2021-2032) & (K Units) Figure 20. China Cyclizine Sales YoY (2021-2032) & (K Units) Figure 21. Asia (Excluding China) Cyclizine Sales YoY (2021-2032) & (K Units) Figure 22. South America, Middle East and Africa Cyclizine Sales YoY (2021-2032) & (K Units) Figure 23. Global Cyclizine Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global Cyclizine Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global Cyclizine Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Cyclizine Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global Cyclizine Revenue Market Share by Type (2021-2032) Figure 29. Global Cyclizine Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 30. Global Cyclizine Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Cyclizine Sales Market Share by Type (2021-2032) Figure 32. Global Cyclizine Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Cyclizine Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 34. Global Cyclizine Revenue Market Share by Application (2021-2032) Figure 35. Global Cyclizine Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 36. Global Cyclizine Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Cyclizine Sales Market Share by Application (2021-2032) Figure 38. North America Cyclizine Revenue Share by Type (2021-2032) Figure 39. North America Cyclizine Sales Share by Type (2021-2032) Figure 40. North America Cyclizine Revenue Share by Application (2021-2032) Figure 41. North America Cyclizine Sales Share by Application (2021-2032) Figure 42. North America Cyclizine Revenue Share by Country (2021-2032) Figure 43. North America Cyclizine Sales Share by Country (2021-2032) Figure 44. Europe Cyclizine Revenue Share by Type (2021-2032) Figure 45. Europe Cyclizine Sales Share by Type (2021-2032) Figure 46. Europe Cyclizine Revenue Share by Application (2021-2032) Figure 47. Europe Cyclizine Sales Share by Application (2021-2032) Figure 48. Europe Cyclizine Revenue Share by Country (2021-2032) Figure 49. Europe Cyclizine Sales Share by Country (2021-2032) Figure 50. China Cyclizine Revenue Share by Type (2021-2032) Figure 51. China Cyclizine Sales Share by Type (2021-2032) Figure 52. China Cyclizine Revenue Share by Application (2021-2032) Figure 53. China Cyclizine Sales Share by Application (2021-2032) Figure 54. Asia Cyclizine Revenue Share by Type (2021-2032) Figure 55. Asia Cyclizine Sales Share by Type (2021-2032) Figure 56. Asia Cyclizine Revenue Share by Application (2021-2032) Figure 57. Asia Cyclizine Sales Share by Application (2021-2032) Figure 58. Asia Cyclizine Revenue Share by Country (2021-2032) Figure 59. Asia Cyclizine Sales Share by Country (2021-2032) Figure 60. SAMEA Cyclizine Revenue Share by Type (2021-2032) Figure 61. SAMEA Cyclizine Sales Share by Type (2021-2032) Figure 62. SAMEA Cyclizine Revenue Share by Application (2021-2032) Figure 63. SAMEA Cyclizine Sales Share by Application (2021-2032) Figure 64. SAMEA Cyclizine Revenue Share by Country (2021-2032) Figure 65. SAMEA Cyclizine Sales Share by Country (2021-2032) Figure 66. Cyclizine Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Cyclizine Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Oral
  • Injection
Applications
  • Migraine
  • Motion Sickness
Companies covered
  • Teva
  • Glaxosmithkline
  • Wockhardt UK
  • Wabosan Arzneimittel
  • Pharmascript Limited
  • P and D Pharmaceuticals
  • Be-Tabs Pharmaceuticals
  • Aspen Pharmacare
  • Amoun Pharmaceutical
  • Amco
  • Aft Pharmaceuticals
  • Advanz Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Cyclizine Market by Type
  3. 1.2.1 Global Cyclizine Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Oral
  5. 1.2.3 Injection
  6. 1.3 Cyclizine Market by Application
  7. 1.3.1 Global Cyclizine Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Migraine
  9. 1.3.3 Motion Sickness
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Cyclizine Market Dynamics
  1. 2.1 Cyclizine Industry Trends
  2. 2.2 Cyclizine Industry Drivers
  3. 2.3 Cyclizine Industry Opportunities and Challenges
  4. 2.4 Cyclizine Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Cyclizine Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Cyclizine Revenue by Region
  3. 3.2.1 Global Cyclizine Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Cyclizine Revenue by Region (2021-2026)
  5. 3.2.3 Global Cyclizine Revenue by Region (2027-2032)
  6. 3.2.4 Global Cyclizine Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Cyclizine Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Cyclizine Sales by Region
  9. 3.4.1 Global Cyclizine Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Cyclizine Sales by Region (2021-2026)
  11. 3.4.3 Global Cyclizine Sales by Region (2027-2032)
  12. 3.4.4 Global Cyclizine Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Cyclizine Revenue by Manufacturers
  2. 4.1.1 Global Cyclizine Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Cyclizine Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Cyclizine Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Cyclizine Sales by Manufacturers
  6. 4.2.1 Global Cyclizine Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Cyclizine Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Cyclizine Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Cyclizine Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Cyclizine Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Cyclizine Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Cyclizine Manufacturers, Product Type & Application
  13. 4.7 Global Cyclizine Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Cyclizine Market CR5 and HHI
  16. 4.8.2 2025 Cyclizine Tier 1, Tier 2, and Tier 3
5 Cyclizine Market by Type
  1. 5.1 Global Cyclizine Revenue by Type
  2. 5.1.1 Global Cyclizine Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Cyclizine Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Cyclizine Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Cyclizine Sales by Type
  6. 5.2.1 Global Cyclizine Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Cyclizine Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Cyclizine Sales Market Share by Type (2021-2032)
  9. 5.3 Global Cyclizine Price by Type
6 Cyclizine Market by Application
  1. 6.1 Global Cyclizine Revenue by Application
  2. 6.1.1 Global Cyclizine Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Cyclizine Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Cyclizine Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Cyclizine Sales by Application
  6. 6.2.1 Global Cyclizine Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Cyclizine Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Cyclizine Sales Market Share by Application (2021-2032)
  9. 6.3 Global Cyclizine Price by Application
7 Company Profiles
  1. 7.1 Teva
  2. 7.1.1 Teva Company Information
  3. 7.1.2 Teva Business Overview
  4. 7.1.3 Teva Cyclizine Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Teva Cyclizine Product Portfolio
  6. 7.1.5 Teva Recent Developments
  7. 7.2 Glaxosmithkline
  8. 7.2.1 Glaxosmithkline Company Information
  9. 7.2.2 Glaxosmithkline Business Overview
  10. 7.2.3 Glaxosmithkline Cyclizine Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Glaxosmithkline Cyclizine Product Portfolio
  12. 7.2.5 Glaxosmithkline Recent Developments
  13. 7.3 Wockhardt UK
  14. 7.3.1 Wockhardt UK Company Information
  15. 7.3.2 Wockhardt UK Business Overview
  16. 7.3.3 Wockhardt UK Cyclizine Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Wockhardt UK Cyclizine Product Portfolio
  18. 7.3.5 Wockhardt UK Recent Developments
  19. 7.4 Wabosan Arzneimittel
  20. 7.4.1 Wabosan Arzneimittel Company Information
  21. 7.4.2 Wabosan Arzneimittel Business Overview
  22. 7.4.3 Wabosan Arzneimittel Cyclizine Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Wabosan Arzneimittel Cyclizine Product Portfolio
  24. 7.4.5 Wabosan Arzneimittel Recent Developments
  25. 7.5 Pharmascript Limited
  26. 7.5.1 Pharmascript Limited Company Information
  27. 7.5.2 Pharmascript Limited Business Overview
  28. 7.5.3 Pharmascript Limited Cyclizine Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Pharmascript Limited Cyclizine Product Portfolio
  30. 7.5.5 Pharmascript Limited Recent Developments
  31. 7.6 P and D Pharmaceuticals
  32. 7.6.1 P and D Pharmaceuticals Company Information
  33. 7.6.2 P and D Pharmaceuticals Business Overview
  34. 7.6.3 P and D Pharmaceuticals Cyclizine Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 P and D Pharmaceuticals Cyclizine Product Portfolio
  36. 7.6.5 P and D Pharmaceuticals Recent Developments
  37. 7.7 Be-Tabs Pharmaceuticals
  38. 7.7.1 Be-Tabs Pharmaceuticals Company Information
  39. 7.7.2 Be-Tabs Pharmaceuticals Business Overview
  40. 7.7.3 Be-Tabs Pharmaceuticals Cyclizine Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Be-Tabs Pharmaceuticals Cyclizine Product Portfolio
  42. 7.7.5 Be-Tabs Pharmaceuticals Recent Developments
  43. 7.8 Aspen Pharmacare
  44. 7.8.1 Aspen Pharmacare Company Information
  45. 7.8.2 Aspen Pharmacare Business Overview
  46. 7.8.3 Aspen Pharmacare Cyclizine Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Aspen Pharmacare Cyclizine Product Portfolio
  48. 7.8.5 Aspen Pharmacare Recent Developments
  49. 7.9 Amoun Pharmaceutical
  50. 7.9.1 Amoun Pharmaceutical Company Information
  51. 7.9.2 Amoun Pharmaceutical Business Overview
  52. 7.9.3 Amoun Pharmaceutical Cyclizine Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Amoun Pharmaceutical Cyclizine Product Portfolio
  54. 7.9.5 Amoun Pharmaceutical Recent Developments
  55. 7.10 Amco
  56. 7.10.1 Amco Company Information
  57. 7.10.2 Amco Business Overview
  58. 7.10.3 Amco Cyclizine Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Amco Cyclizine Product Portfolio
  60. 7.10.5 Amco Recent Developments
  61. 7.11 Aft Pharmaceuticals
  62. 7.11.1 Aft Pharmaceuticals Company Information
  63. 7.11.2 Aft Pharmaceuticals Business Overview
  64. 7.11.3 Aft Pharmaceuticals Cyclizine Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Aft Pharmaceuticals Cyclizine Product Portfolio
  66. 7.11.5 Aft Pharmaceuticals Recent Developments
  67. 7.12 Advanz Pharma
  68. 7.12.1 Advanz Pharma Company Information
  69. 7.12.2 Advanz Pharma Business Overview
  70. 7.12.3 Advanz Pharma Cyclizine Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Advanz Pharma Cyclizine Product Portfolio
  72. 7.12.5 Advanz Pharma Recent Developments
8 North America
  1. 8.1 North America Cyclizine Market Size by Type
  2. 8.1.1 North America Cyclizine Revenue by Type (2021-2032)
  3. 8.1.2 North America Cyclizine Sales by Type (2021-2032)
  4. 8.1.3 North America Cyclizine Price by Type (2021-2032)
  5. 8.2 North America Cyclizine Market Size by Application
  6. 8.2.1 North America Cyclizine Revenue by Application (2021-2032)
  7. 8.2.2 North America Cyclizine Sales by Application (2021-2032)
  8. 8.2.3 North America Cyclizine Price by Application (2021-2032)
  9. 8.3 North America Cyclizine Market Size by Country
  10. 8.3.1 North America Cyclizine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Cyclizine Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Cyclizine Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Cyclizine Market Size by Type
  2. 9.1.1 Europe Cyclizine Revenue by Type (2021-2032)
  3. 9.1.2 Europe Cyclizine Sales by Type (2021-2032)
  4. 9.1.3 Europe Cyclizine Price by Type (2021-2032)
  5. 9.2 Europe Cyclizine Market Size by Application
  6. 9.2.1 Europe Cyclizine Revenue by Application (2021-2032)
  7. 9.2.2 Europe Cyclizine Sales by Application (2021-2032)
  8. 9.2.3 Europe Cyclizine Price by Application (2021-2032)
  9. 9.3 Europe Cyclizine Market Size by Country
  10. 9.3.1 Europe Cyclizine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Cyclizine Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Cyclizine Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Cyclizine Market Size by Type
  2. 10.1.1 China Cyclizine Revenue by Type (2021-2032)
  3. 10.1.2 China Cyclizine Sales by Type (2021-2032)
  4. 10.1.3 China Cyclizine Price by Type (2021-2032)
  5. 10.2 China Cyclizine Market Size by Application
  6. 10.2.1 China Cyclizine Revenue by Application (2021-2032)
  7. 10.2.2 China Cyclizine Sales by Application (2021-2032)
  8. 10.2.3 China Cyclizine Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Cyclizine Market Size by Type
  2. 11.1.1 Asia Cyclizine Revenue by Type (2021-2032)
  3. 11.1.2 Asia Cyclizine Sales by Type (2021-2032)
  4. 11.1.3 Asia Cyclizine Price by Type (2021-2032)
  5. 11.2 Asia Cyclizine Market Size by Application
  6. 11.2.1 Asia Cyclizine Revenue by Application (2021-2032)
  7. 11.2.2 Asia Cyclizine Sales by Application (2021-2032)
  8. 11.2.3 Asia Cyclizine Price by Application (2021-2032)
  9. 11.3 Asia Cyclizine Market Size by Country
  10. 11.3.1 Asia Cyclizine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Cyclizine Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Cyclizine Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Cyclizine Market Size by Type
  2. 12.1.1 SAMEA Cyclizine Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Cyclizine Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Cyclizine Price by Type (2021-2032)
  5. 12.2 SAMEA Cyclizine Market Size by Application
  6. 12.2.1 SAMEA Cyclizine Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Cyclizine Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Cyclizine Price by Application (2021-2032)
  9. 12.3 SAMEA Cyclizine Market Size by Country
  10. 12.3.1 SAMEA Cyclizine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Cyclizine Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Cyclizine Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Cyclizine Value Chain Analysis
  2. 13.1.1 Cyclizine Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Cyclizine Production Mode & Process
  6. 13.2 Cyclizine Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Cyclizine Distributors
  9. 13.2.3 Cyclizine Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst